Imiquimod inhibits growth and induces differentiation of myeloid leukemia cell lines
Abstract Background The antitumoral effects of different Toll-like receptor (TLRs) agonists is mediated by activating immune responses to suppress tumors growth, although TLR ligands may also have a direct effect on tumoral cells. Given that TLR signaling induces hematopoietic cell differentiations...
Main Authors: | Eva Villamón, Javier González-Fernández, Esperanza Such, José Vicente Cervera, Daniel Gozalbo, M. Luisa Gil |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-018-0515-1 |
Similar Items
-
Malignant Melanoma Treated with Topical Imiquimod: A Bespoke Treatment That Spared the Amputation
by: Emanuele Verga, et al.
Published: (2019-01-01) -
Imiquimod 5% cream in topical treatment of facial basal cell carcinoma
by: Grubor Svetlana D., et al.
Published: (2015-01-01) -
Revisiting Imiquimod for Treatment of Folliculotropic Mycosis Fungoides: A Case Report and Review of the Literature
by: Doaa Shalabi, et al.
Published: (2019-08-01) -
Association between TLR2 and TLR4 Expression and Response to Induction Therapy in Acute Myeloid Leukemia Patients
by: Mani Ramzi, et al.
Published: (2018-07-01) -
TLR7 Activation of Macrophages by Imiquimod Inhibits HIV Infection through Modulation of Viral Entry Cellular Factors
by: Feng-Zhen Meng, et al.
Published: (2021-07-01)